Načítá se...

Programmed cell death-ligand 1 assessment in urothelial carcinoma: prospect and limitation

Programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) inhibition has revolutionized the treatment paradigm of urothelial carcinoma (UC). Several PD-L1 assays are conducted to formulate appropriate treatment decisions for PD-1/PD-L1 target therapy in UC. However, each assay has its o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pathol Transl Med
Hlavní autoři: Lee, Kyu Sang, Choe, Gheeyoung
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society of Pathologists and the Korean Society for Cytopathology 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8141973/
https://ncbi.nlm.nih.gov/pubmed/33823566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2021.02.22
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!